Home » Genzyme Wins Restrictions on Generic Arthritis Drug Price
Genzyme Wins Restrictions on Generic Arthritis Drug Price
Genzyme won a preliminary injunction in its infringement suit against Seikagaku over osteoarthritis knee pain treatment Synvisc-One, setting a minimum price at which the Japanese pharmaceutical maker can sell its lower-cost generic.
Law360
Law360
Upcoming Events
-
07May
-
14May
-
30May